UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 7, 2024
Accession Number:
0001193125-24-154320
Submission Type:
POS AM
CIK:
0001805890
Company Name:
Fusion Pharmaceuticals Inc.
File Number:
333-272713